Istvan Bodrogi

Author PubWeight™ 45.40^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.	Lancet	2010	19.74
2	Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial.	Lancet	2007	15.92
3	Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial.	J Clin Oncol	2009	2.88
4	The Y deletion gr/gr and susceptibility to testicular germ cell tumor.	Am J Hum Genet	2005	2.26
5	Genome-wide linkage screen for testicular germ cell tumour susceptibility loci.	Hum Mol Genet	2006	2.23
6	The International Testicular Cancer Linkage Consortium: a clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred.	Urol Oncol	2009	1.70
7	Analysis of the DND1 gene in men with sporadic and familial testicular germ cell tumors.	Genes Chromosomes Cancer	2008	1.05
8	Younger age-at-diagnosis for familial malignant testicular germ cell tumor.	Fam Cancer	2009	0.80
9	Expression of HER-2/neu in testicular tumors.	Anticancer Res	2003	0.76